rethinkPeptides Search
Menu
Study breakdown

Molecular Forms of Natriuretic Peptides in Heart Failure: Why It Matters Which Form You Measure

evidence
The takeaway

Multiple molecular forms of BNP and NT-proBNP circulate in heart failure (proBNP, glycosylated variants, degradation products), with assay specificity for different forms affecting clinical measurements.

Key finding

Multiple molecular forms of BNP and NT-proBNP circulate in heart failure (proBNP, glycosylated variants, degradation products), with assay specificity

What the researchers found

Multiple molecular forms of BNP and NT-proBNP circulate in heart failure (proBNP, glycosylated variants, degradation products), with assay specificity for different forms affecting clinical measurements.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Molecular Forms of Natriuretic Peptides in Heart Failure: Why It Matters Which Form You Measure
What was found?
Multiple molecular forms of BNP and NT-proBNP circulate in heart failure (proBNP, glycosylated variants, degradation products), with assay specificity for different forms affecting clinical measurements.

Read the original research

Molecular forms of natriuretic peptides in heart failure and their implications.

Heart (British Cardiac Society), 96(6), 419-24

Citation

Xu-Cai, Ye Olivia; Wu, Qingyu. (2010). Molecular forms of natriuretic peptides in heart failure and their implications.. Heart (British Cardiac Society), 96(6), 419-24. https://doi.org/10.1136/hrt.2008.164145